Tens of thousands of Americans are at risk of losing access to HIV treatment as nearly 20 states tighten eligibility rules for AIDS Drug Assistance Programs, known as ADAPs.
By Deena Beasley May 5 (Reuters) - Use of Gilead Sciences' Yeztugo, a twice-yearly injection to prevent HIV infection, has ...
Medications have kept Tori Samuel’s HIV at bay for decades. The part-time worker from Ocala, Florida, has thrived, marrying her husband and giving birth to three children, none of whom have the virus.
Individual's in Florida must now earn no more than $20,748 per year to qualify. The previous limit was $63,840. HealthDay News — A growing number of states are rolling back financial help for HIV ...
Gilead Sciences’ twice-yearly HIV prevention injection Yeztugo has seen rising uptake since its U.S. launch, but patients still face insurance coverage gaps and cost-sharing barriers. While more than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results